购物车
您的购物车当前为空
Tubulin aggregation-IN-17 (compound 23g) 是一种 tubulin 聚合的有效抑制剂。Tubulin aggregation-IN-17 具有微管蛋白解聚作用,能够诱导细胞凋亡并抑制迁移。Tubulin aggregation-IN-17 具有潜力进行癌症疾病的研究。

Tubulin aggregation-IN-17 (compound 23g) 是一种 tubulin 聚合的有效抑制剂。Tubulin aggregation-IN-17 具有微管蛋白解聚作用,能够诱导细胞凋亡并抑制迁移。Tubulin aggregation-IN-17 具有潜力进行癌症疾病的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 |
| 产品描述 | Tubulin aggregation-IN-17 (compound 23g) is a potent inhibitor of tubulin aggregation. tubulin aggregation-IN-17 has a microtubulin-depolymerising effect, induces apoptosis and inhibits migration. tubulin aggregation-IN-17 has potential for cancer disease research. Tubulin aggregation-IN-17 has potential for cancer disease research. |
| 分子量 | 429.46 |
| 分子式 | C26H23NO5 |
| CAS No. | 2454175-89-2 |
| Smiles | C(\C(=O)C1=CC(OC)=C(OC)C(OC)=C1)(=C/C2=CC=C(C)C=C2)/C3=NC=4C(O3)=CC=CC4 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多